These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35799569)

  • 1. Outcomes following the use of angiotensin II in patients with postoperative vasoplegic syndrome: A case series.
    Konkol SB; Morrisette MJ; Hulse MC; Enfield KB; Mihalek AD
    Ann Card Anaesth; 2022; 25(3):359-361. PubMed ID: 35799569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic Human Angiotensin II for Postcardiopulmonary Bypass Vasoplegic Shock.
    Wieruszewski PM; Radosevich MA; Kashani KB; Daly RC; Wittwer ED
    J Cardiothorac Vasc Anesth; 2019 Nov; 33(11):3080-3084. PubMed ID: 31060933
    [No Abstract]   [Full Text] [Related]  

  • 3. Angiotensin II for Critically Ill Patients With Shock After Heart Transplant.
    Cutler NS; Rasmussen BM; Bredeck JF; Lata AL; Khanna AK
    J Cardiothorac Vasc Anesth; 2021 Sep; 35(9):2756-2762. PubMed ID: 32868151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Angiotensin II for Post Cardiopulmonary Bypass Vasoplegic Syndrome.
    Evans A; McCurdy MT; Weiner M; Zaku B; Chow JH
    Ann Thorac Surg; 2019 Jul; 108(1):e5-e7. PubMed ID: 30582924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Angiotensin II in Severe Vasoplegia After Left Pneumonectomy Requiring Cardiopulmonary Bypass: A Renin Response Analysis.
    Trethowan B; Michaud CJ; Fifer S
    Crit Care Med; 2020 Oct; 48(10):e912-e915. PubMed ID: 32931196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasoplegic syndrome following cardiothoracic surgery-review of pathophysiology and update of treatment options.
    Busse LW; Barker N; Petersen C
    Crit Care; 2020 Feb; 24(1):36. PubMed ID: 32019600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. When All Else Fails: Novel Use of Angiotensin II for Vasodilatory Shock: A Case Report.
    Chow JH; Galvagno SM; Tanaka KA; Mazzeffi MA; Chancer Z; Henderson R; McCurdy MT
    A A Pract; 2018 Oct; 11(7):175-180. PubMed ID: 29688923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasoplegic syndrome after cardiovascular surgery: A review of pathophysiology and outcome-oriented therapeutic management.
    Datt V; Wadhhwa R; Sharma V; Virmani S; Minhas HS; Malik S
    J Card Surg; 2021 Oct; 36(10):3749-3760. PubMed ID: 34251716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasoplegia After Cardiovascular Procedures-Pathophysiology and Targeted Therapy.
    Shaefi S; Mittel A; Klick J; Evans A; Ivascu NS; Gutsche J; Augoustides JGT
    J Cardiothorac Vasc Anesth; 2018 Apr; 32(2):1013-1022. PubMed ID: 29223724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the evidence for angiotensin II for the treatment of vasoplegia in critically ill cardiothoracic surgery patients.
    Chow JH; Wittwer ED; Wieruszewski PM; Khanna AK
    J Thorac Cardiovasc Surg; 2022 Apr; 163(4):1407-1414. PubMed ID: 33875258
    [No Abstract]   [Full Text] [Related]  

  • 11. Angiotensin II: A Review of Current Literature.
    Alam A; Sovic W; Gill J; Ragula N; Salem M; Hughes GJ; Colbert GB; Mooney JL
    J Cardiothorac Vasc Anesth; 2022 Apr; 36(4):1180-1187. PubMed ID: 34452817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Use of Angiotensin II for the Treatment of Post-cardiopulmonary Bypass Vasoplegia.
    Papazisi O; Palmen M; Danser AHJ
    Cardiovasc Drugs Ther; 2022 Aug; 36(4):739-748. PubMed ID: 33085026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylene Blue for Vasoplegic Syndrome.
    Booth AT; Melmer PD; Tribble B; Mehaffey JH; Tribble C
    Heart Surg Forum; 2017 Oct; 20(5):E234-E238. PubMed ID: 29087290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Angiotensin II for Vasoplegic Shock in a Combined Heart and Liver Transplant Recipient with Systolic Anterior Motion Physiology.
    Wieruszewski PM; Sims CR; Daly RC; Taner T; Wittwer ED
    J Cardiothorac Vasc Anesth; 2019 Aug; 33(8):2366-2367. PubMed ID: 31076311
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of Intravenous Hydroxocobalamin without Methylene Blue for Refractory Vasoplegic Syndrome After Cardiopulmonary Bypass.
    Peyko V; Finamore M
    Am J Case Rep; 2021 Jun; 22():e930890. PubMed ID: 34143764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perioperative infusion of low- dose of vasopressin for prevention and management of vasodilatory vasoplegic syndrome in patients undergoing coronary artery bypass grafting-A double-blind randomized study.
    Papadopoulos G; Sintou E; Siminelakis S; Koletsis E; Baikoussis NG; Apostolakis E
    J Cardiothorac Surg; 2010 Mar; 5():17. PubMed ID: 20346182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The additional use of methylene blue has a decatecholaminisation effect on cardiac vasoplegic syndrome after cardiac surgery.
    Petermichl W; Gruber M; Schoeller I; Allouch K; Graf BM; Zausig YA
    J Cardiothorac Surg; 2021 Jul; 16(1):205. PubMed ID: 34321019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment With Angiotensin II Is Associated With Rapid Blood Pressure Response and Vasopressor Sparing in Patients With Vasoplegia After Cardiac Surgery: A Post-Hoc Analysis of Angiotensin II for the Treatment of High-Output Shock (ATHOS-3) Study.
    Klijian A; Khanna AK; Reddy VS; Friedman B; Ortoleva J; Evans AS; Panwar R; Kroll S; Greenfeld CR; Chatterjee S
    J Cardiothorac Vasc Anesth; 2021 Jan; 35(1):51-58. PubMed ID: 32868152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vasoplegic syndrome and its treatment with vasopressin during cardiac surgery with cardiopulmonary bypass].
    Gilbert M; Lema G
    Rev Med Chil; 2011 Mar; 139(3):368-72. PubMed ID: 21879171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasoplegic Syndrome in Patients Undergoing Cardiac Surgery: A Literature Review.
    Nash CM
    AACN Adv Crit Care; 2021 Jun; 32(2):137-145. PubMed ID: 34161970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.